FY2025

14 August 2025; Company Announcement Full-Year Results 2024-25 - Acrobat pdf 364k Highlights Revenue from ordinary activities $213.0m – up 31.9% Underlying profit before tax $163.3m – up 40.2% Net profit $115.2m – up 39.2% Cash and other financial assets $210.7m – up 35.5% Company remains debt-free Record year for new contract wins, contract renewals and sale of additional modules to existing clients. Fully-franked final dividend 30c per share Leading health imaging company Pro Medicus Limited [ASX: PME] today announced a full-year net profit of $115.2 million for the twelve months to the end of June 2025, 39.2% higher than the previous corresponding period. Revenue from ordinary activities was $ 213.0 million, up 31.9%. The company’s cash and other financial assets at the end of June 2025 were $210.7 million, an increase of 35.5%. Pro Medicus announced a fully-franked final dividend of 30c per share. The company remains debt-free. Revenue increased in all key jurisdictions: North America up 35.8%, Australia up 4.9% and Germany up 8.6%. During the year Pro Medicus announced $520 million in new contracts, including: A $330 million, ten-year contract with Trinity Health, one of the largest not-for-profit health care systems in the United States. A $30 million, 7-year contract with Duly Health and Care, the largest independent, multi-specialty physician-directed medical group in the USA Midwest. A $33 million, 9-year contract with University of Kentucky, the preeminent academic health system in Kentucky. A $5 million, 7-year contract with Lurie Children’s Hospital, a nationally ranked paediatric acute care children's hospital in Chicago. A $53 million, 7-year contract with BayCare, the leading health care system in the Tampa Bay and central Florida regions of the USA. A $40 million, 7-year contract with Lucid